Edgar Filing: GREENWAY MEDICAL TECHNOLOGIES INC

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â INVESTOR AB

2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2012

3. Issuer Name and Ticker or Trading Symbol
GREENWAY MEDICAL TECHNOLOGIES INC [GWAY]

(Last)

(First)

(Middle)

C/O INVESTOR GROWTH CAPITAL,Â ONE ROCKEFELLER PLAZA, SUITE 2801

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

NEW YORK,Â NYÂ 10020

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,235,295	I	By Investor Growth Capital Limited ⁽¹⁾ ⁽²⁾
Common Stock	529,411	I	By Investor Group, L.P. ⁽¹⁾ ⁽²⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Convertible Preferred Stock	Â ⁽³⁾	Â ⁽³⁾	Common Stock	2,210,526 ⁽³⁾	$ ⁽³⁾	I	By Investor Growth Capital Limited ⁽¹⁾ ⁽²⁾
Series A Convertible Preferred Stock	Â ⁽³⁾	Â ⁽³⁾	Common Stock	947,368 ⁽³⁾	$ ⁽³⁾	I	By Investor Group, L.P. ⁽¹⁾ ⁽²⁾
Series B Convertible Preferred Stock	Â ⁽⁴⁾	Â ⁽⁴⁾	Common Stock	768,637 ⁽⁴⁾	$ ⁽⁴⁾	I	By Investor Growth Capital Limited ⁽¹⁾ ⁽²⁾
Series B Convertible Preferred Stock	Â ⁽⁴⁾	Â ⁽⁴⁾	Common Stock	329,416 ⁽⁴⁾	$ ⁽⁴⁾	I	By Investor Group, L.P. ⁽¹⁾ ⁽²⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
INVESTOR AB C/O INVESTOR GROWTH CAPITAL ONE ROCKEFELLER PLAZA, SUITE 2801 NEW YORK,Â NYÂ 10020	Â	Â X	Â	Â

Signatures

/s/ Stephen Campe		01/31/2012
^**Signature of Reporting Person		Date
/s/ Michael Oporto		01/31/2012
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Investor AB, a publicly held Swedish company (the "Reporting Person"), through one or more entities, (i) wholly owns Investor Growth Capital Limited ("Investor Capital"), a Guernsey company, and (ii) is the ultimate general partner of Investor Group, L.P. ("Investor Group"), a Guernsey limited partnership. As a result of the foregoing, the Reporting Person possesses the sole power to vote and the sole power to direct the disposition of the shares of Greenway Medical Technologies, Inc. (the "Company") held by each of Investor Capital and Investor Group.
(2)	The Reporting Person's interest in all of the Company's securities is limited to the extent of its pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents shall be deemed to constitute an admission by the Reporting Person or any other person/entity that he or it was or is the beneficial owner of any of the Company's securities for purposes of Section 16 of the Securities and Exchange Act of 1934 (the "Act"), or for any other purpose.
(3)	Each share of Series A Convertible Preferred Stock will automatically convert into 1.263 shares of common stock in connection with the completion of the Company's initial public offering and has no expiration date.
(4)	Each share of Series B Convertible Preferred Stock will automatically convert into one share of common stock in connection with the completion of the Company's initial public offering and has no expiration date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.